Why are PEXA shares crashing 11% today?

Rough end to the week for the property settlement specialist.

| More on:

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

PEXA Group Ltd (ASX: PXA) shares had been on a roll over the past month, rallying by more than 30% to reach a recent peak of $17.18 per share. 

However, this surge has turned out to be short-lived.

PEXA shares are trading 11% lower at the time of writing, changing hands at $15.05 apiece.

This comes after the company released its FY25 results this morning. 

Evidently, its results for the year failed to live up to market expectations, triggering a sharp sell-off. 

Let's find out what happened. 

A man sits at a desk holding a small replica house in his hand, upset at the sale of his property.

Image source: Getty Images

What did PEXA report?

Revenue of $393.6 million grew by 16% from the previous year.

Group operating earnings (EBITDA) of $134 million increased by 21%, with the EBITDA margin inching up by 1.3 percentage points to 34.1%.

Free cash flow also jumped by 45% to $56 million.

However, adjusted net profit after tax (NPATA) dipped by 6% to $41.1 million.

Statutory NPAT fared even worse.

Here, the company reported a $76.1 million loss in FY25 following a 323% fall in this metric.

That said, PEXA's financial leverage improved from 2.5x last year to 1.8x in FY25.

What else happened in FY25?

PEXA is a digital property exchange and data insights business.

In other words, the group digitises and streamlines the process of buying and selling property in Australia, replacing traditional paper-based settlement processes.

PEXA also recently expanded internationally with a digital property transaction solutions business in the UK.

In FY25, the company's Australian business unit, PEXA Exchange, saw revenue lift by 7.5% to $313.8 million.

Management attributed this performance to continued growth in transaction volumes, the completion of its national rollout, and price increases.

In turn, EBITDA of $172.5 million grew by 8.4% for PEXA Exchange, with an EBITDA margin of 55.0%.

PEXA's international business also delivered an improved operating performance, headlined by 15.4% revenue growth to $60.7 million on a pro-forma basis.

Management noted that FY25 was a foundational year for the UK operations as the group finalised preparations for the launch of its platform.

PEXA believes that its existing product portfolio is capable of servicing 70% of UK property transactions, with further development planned to extend coverage to 80%.

The company's digital solutions arm also delivered a 21.7% rise in revenue to $19.1 million.

That said, PEXA recently commenced a strategic review of this business unit, which could result in either a divestment or further investment.

What did management say?

Commenting on the result, PEXA CEO Russell Cohen said:

In FY25, we grew Group revenue by 16%, improved cash generation, and strengthened our leverage, driven by contributions across all business segments. The Exchange in Australia now has 90% market coverage, and in the UK our product suite is ready for launch in early FY26. We were thrilled to see our UK lender engagement come to fruition through NatWest's written commitment in July 2025 to an implementation program. In Digital Solutions, we scaled the business and improved margins. 

PEXA share price snapshot 

PEXA shares have been rocked by high interest rates over the past few years.

However, the property settlement company has made a comeback in recent times. 

Even factoring in today's decline, PEXA shares are up by 17% over the past year. 

Motley Fool contributor Bart Bogacz has no position in any of the stocks mentioned. The Motley Fool Australia's parent company Motley Fool Holdings Inc. has positions in and has recommended PEXA Group. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

More on Earnings Results

A businessman points to an arrow going up on a graph, indicating a share price rise for an ASX company.
Earnings Results

Up 98% since March, why are AMP shares leaping higher again on Thursday?

ASX investors are piling into AMP shares on Thursday. But why?

Read more »

Two smiling work colleagues discuss an investment at their office.
Earnings Results

Argo Investments FY26 earnings: Record dividends and outlook

Argo’s board has announced a move to quarterly dividend payments from next year.

Read more »

A woman wine tasting in a bottle shop.
Consumer Staples & Discretionary Shares

Endeavour Group share price in focus after FY26 earnings drop

The Dan Murphy's owner has released its results this morning.

Read more »

A group of three young men sit on a sofa in a home environment with a bowl of popcorn and beer bottles in front of them cheering on one of their teams on a phone.
Earnings Results

Light & Wonder earnings: Q2 profit and recurring revenue up in FY26

Recurring revenue reached US$580 million in the second quarter.

Read more »

A casually dressed woman at home on her couch looks at index fund charts on her laptop.
Earnings Results

Pinnacle Investment Management: Profit up 31% on record funds inflow

The company revealed record net inflows of $33.4 billion in FY26.

Read more »

Business people discussing project on digital tablet.
Earnings Results

Charter Hall Social Infrastructure REIT lifts earnings and distributions in FY26

The REIT has provided upbeat guidance for FY27.

Read more »

Smiling man working on his laptop.
Earnings Results

Credit Corp profit jumps 12% with fully franked dividend boost

The debt collector is paying a fully franked final dividend of 45.5 cents per share.

Read more »

Doctor with stethoscope around neck shrugging.
Earnings Results

CSL reports on 18 August. Can the healthcare giant arrest the slide?

A make-or-break result for Australia's fallen biotech giant.

Read more »